Walleye Capital’s Editas Medicine EDIT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-372,100	Closed	-$763K	–	4541
2025 Q4	$763K	Buy	372,100 +239,500	+181%	+$691K	﹤0.01%	2644
2025 Q3	$460K	Buy	+132,600	New	+$370K	﹤0.01%	2682
2025 Q1	–	Sell	-82,600	Closed	-$105K	–	4449
2024 Q4	$105K	Sell	82,600 -8,800	-10%	-$22.4K	﹤0.01%	4117
2024 Q3	$312K	Sell	91,400 -400	-0.4%	-$1.74K	﹤0.01%	3700
2024 Q2	$429K	Buy	91,800 +43,300	+89%	+$244K	﹤0.01%	3638
2024 Q1	$360K	Buy	+48,500	New	+$403K	﹤0.01%	3489
2023 Q3	–	Sell	-15,300	Closed	-$126K	–	4982
2023 Q2	$126K	Sell	15,300 -7,300	-32%	-$63.6K	﹤0.01%	3335
2023 Q1	$164K	Buy	22,600 +2,100	+10%	+$18.7K	﹤0.01%	2619
2022 Q4	$182K	Buy	20,500 +20,300	+10,150%	+$223K	﹤0.01%	2099
2022 Q3	$2K	Buy	+200	New	+$3.12K	﹤0.01%	3058
2020 Q2	–	Sell	-9,000	Closed	-$178K	–	697
2020 Q1	$178K	Sell	9,000 -5,000	-36%	-$126K	0.04%	467
2019 Q4	$415K	Sell	14,000 -4,200	-23%	-$105K	0.03%	770
2019 Q3	$414K	Buy	18,200 +2,500	+16%	+$61.9K	0.02%	843
2019 Q2	$388K	Buy	15,700 +14,000	+824%	+$334K	0.04%	615
2019 Q1	$42K	Buy	+1,700	New	+$38.5K	0.01%	1245